Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Eli Lilly to provide Migraine drug Reyvow

      Eli Lilly to provide Migraine drug Reyvow

      Farhat Nasim4 Feb 2020 9:00 AM IST
      New Delhi: Eli Lilly and Company announced recently that REYVOW (lasmiditan) C-V 50 mg and 100 mg tablets, an oral medication for the acute treatment...
      Eli Lilly new insulin to improve glycemic control in diabetics get positive opinion from EMA

      Eli Lilly new insulin to improve glycemic control in diabetics get positive opinion from EMA

      Farhat Nasim3 Feb 2020 3:03 PM IST
      The CHMP opinion is now referred for final action to the European Commission, which grants approval in the European Union. Lilly plans to market the...
      Emcure plea to direct NPPA to review HIV drugs price junked by DoP

      Emcure plea to direct NPPA to review HIV drugs price junked by DoP

      Farhat Nasim3 Feb 2020 1:41 PM IST
      New Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
      NPPA fixes ceiling price of Immunoglobulin therapy, Details

      NPPA fixes ceiling price of Immunoglobulin therapy, Details

      Farhat Nasim2 Feb 2020 1:30 PM IST
      New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers, Government of India has...
      Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind

      Essential medicines price capping resulted in saving of Rs 12500 crore, says Kovind

      Farhat Nasim2 Feb 2020 12:00 PM IST
      Addressing the joint sitting of both houses of Parliament, on the first day of the Budget session here, Kovind said capping of prices of more than...
      Siemens Healthineers supplies ultrasound machines, CT scanner to Wuhan hospitals

      Siemens Healthineers supplies ultrasound machines, CT scanner to Wuhan hospitals

      Farhat Nasim2 Feb 2020 9:00 AM IST
      A spokesman for the separately listed Siemens subsidiary said on Friday the diagnostic machines (two ultrasound machines and a CT scanner) were...
      DPCO has led to increase in prices by about 21pc for cheaper drugs: Survey

      DPCO has led to increase in prices by about 21pc for cheaper drugs: Survey

      Farhat Nasim1 Feb 2020 2:43 PM IST
      The Survey said its estimates also show that the DPCO, 2013 order increased prices by about 21 per cent for the cheaper formulations. However, in the...
      Biocon Biologics gets Rs 536 crore investment from True North Fund

      Biocon Biologics gets Rs 536 crore investment from True North Fund

      Farhat Nasim22 Jan 2020 1:09 PM IST
      New Delhi: Biocon recently announced that Biocon Biologics India has received the subscription money aggregating to Rs. 536.25 crore from Activ Pine...
      GE South Asia gets Mahesh Palashikar as new President, CEO

      GE South Asia gets Mahesh Palashikar as new President, CEO

      Farhat Nasim22 Jan 2020 12:53 PM IST
      As a 20-year GE veteran, Mahesh Palashikar's career progressed through varied, complex assignments in manufacturing operations, global supply...
      Biocon Bengaluru facility clears USFDA inspection

      Biocon Bengaluru facility clears USFDA inspection

      Farhat Nasim21 Jan 2020 1:00 PM IST
      The US Food and Drug Administration (USFDA) conducted a pre-approval inspection of the oral solid dosage manufacturing facility of Biocon Pharma, a...
      Mumbai: Fake pharmacy call centre selling prescription drugs for impotence busted; 2 held

      Mumbai: Fake pharmacy call centre selling prescription drugs for impotence busted; 2 held

      Farhat Nasim21 Jan 2020 11:40 AM IST
      Mumbai: In a major crackdown, Mumbai Crime Branch has busted a racket targeting American Nationals and duping them under the pretext of providing...
      Cipla Patalganga facility gets EIR from USFDA

      Cipla Patalganga facility gets EIR from USFDA

      Farhat Nasim20 Jan 2020 11:52 AM IST
      "Following the inspection by the United States Food and Drug Administration (USFDA) at the Patalganga manufacturing facility of the company from...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok